PMOS — Polycystic Metabolic Ovarian Syndrome

Polycystic Metabolic Ovarian Syndrome (PMOS) is a proposed terminology emphasizing the close relationship between ovarian dysfunction, hormonal imbalance, and metabolic disturbances commonly associated with polycystic ovary syndrome (PCOS). This topic explores the complex interactions among reproductive hormones, insulin resistance, metabolic health, and ovarian function, with a focus on advancing understanding, early recognition, and comprehensive management of affected individuals.

The field encompasses insulin resistance, hyperandrogenism, irregular menstrual cycles, ovulatory dysfunction, metabolic syndrome, obesity, fertility challenges, and long-term risks such as type 2 diabetes and cardiovascular disease. It also highlights the roles of nutrition, physical activity, weight management, reproductive endocrinology, and personalized treatment strategies in improving metabolic and reproductive outcomes.

The World Congress on Gynecology and Women’s Health Care 2027 (WCWH-2027) provides a platform for gynecologists, endocrinologists, reproductive medicine specialists, metabolic health researchers, nutritionists, and healthcare professionals to discuss emerging research, share clinical insights, and explore integrated approaches to hormonal, ovarian, and metabolic health.